•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A10508 Summary:

BILL NOA10508A
 
SAME ASSAME AS S08182-A
 
SPONSORRules (Paulin)
 
COSPNSRDinowitz, Rosenthal L, Ortiz, DenDekker, Buttenschon, Seawright, Lupardo, Blake, Perry, Jacobson, Simon, Fitzpatrick, Bronson
 
MLTSPNSR
 
Amd 6527, 6802 & 6909, Ed L
 
Authorizes licensed pharmacists to administer a vaccine for COVID-19 approved by the United States Food and Drug Administration Center for Biologics Evaulation and Research vaccine product approval process.
Go to top

A10508 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A10508a
 
SPONSOR: Rules (Paulin)
  TITLE OF BILL: An act to amend the education law, in relation to authorizing licensed pharmacists to administer an approved vaccine for COVID-19; and provid- ing for the repeal of such provisions upon expiration thereof   SUMMARY OF PROVISIONS: Section one of the bill amends subdivision 7 of section 6527 of the Education Law to add COVID-19 to the list of diseases for which a licensed physician may prescribe a patient specific order or non-patient specific regimen to a licensed pharmacist for administering immuniza- tions. Section two of the bill amends the definition of "administer" in subdi- vision 22 of section 6802 of the education law to make conforming chang- es. Section three of the bill amends subdivision 7 of section 6909 of the education law to add COVID-19 to the list of diseases for which a certi- fied nurse practitioner may prescribe a patient specific order or non- patient specific regimen to a licensed pharmacist for administering immunizations. Section four of the bill establishes that the bill would take effect no sooner than ninety days from the date of approval of a COVID-19 immuni- zation by the United States Food and Drug Administration's Center for Biologics Evaluation and Research and shall expire and be deemed repealed July 1, 2022 and provided further that this act shall not take effect until the commissioner of health and the commissioner of educa- tion jointly certify that the administration of such immunization pursu- ant to this act would be in the best interest of public health.   JUSTIFICATION: The spread of COVID-19 has illustrated the terrible consequences that a global pandemic can have if there is no available vaccine to guard against transmission of the virus. The necessary, yet drastic measures that New York and other states have undertaken to slow transmission and prevent our health care system from being overwhelmed have had enormous- ly consequential effects for our economy, causing businesses to close and workers to lose their employment. Despite our best efforts, more and more New Yorkers are infected and die with each passing day. Scientists are working as quickly as possible to develop a safe, effec- tive vaccine to provide immunity to COVID-19. It is crucial for public health that once a vaccine is approved by the FDA, we authorize as many health care professionals as possible to administer it to meet the demand, which will likely be enormous.   LEGISLATIVE HISTORY: New Bill   FISCAL IMPLICATIONS: None to the State.   EFFECTIVE DATE: This act shall take effect no sooner than ninety days from the date of approval of a COVID-19 immunization by the United States Food and Drug Administration's Center for Biologics Evaluation and Research and shall expire and be deemed repealed July 1, 2022 and provided further that this act shall not take effect until the commissioner of health and the commissioner of education jointly certify that the administration of such immunization pursuant to this act would be in the best interest of public health.
Go to top

A10508 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                        10508--A
 
                   IN ASSEMBLY
 
                                      May 22, 2020
                                       ___________
 
        Introduced  by  COMMITTEE  ON  RULES  -- (at request of M. of A. Paulin,
          Dinowitz) -- read once and referred to the Committee on Higher  Educa-
          tion  --  committee  discharged,  bill  amended,  ordered reprinted as
          amended and recommitted to said committee
 
        AN ACT to amend the education law, in relation to  authorizing  licensed
          pharmacists  to  administer  an  approved  vaccine  for  COVID-19; and
          providing for the repeal of such provisions upon expiration thereof
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Subdivision  7  of  section 6527 of the education law, as
     2  amended by chapter 46 of the  laws  of  2015,  is  amended  to  read  as
     3  follows:
     4    7.  A  licensed  physician  may prescribe and order a patient specific
     5  order or non-patient specific regimen to a licensed pharmacist, pursuant
     6  to regulations promulgated by the commissioner, and consistent with  the
     7  public health law, for administering immunizations to prevent influenza,
     8  pneumococcal,  acute  herpes zoster, meningococcal, tetanus, diphtheria,
     9  COVID-19, or pertussis disease and medications  required  for  emergency
    10  treatment  of  anaphylaxis.  Nothing in this subdivision shall authorize
    11  unlicensed persons to administer immunizations, vaccines or other drugs.
    12    § 2. Subdivision 22 of section 6802 of the education law,  as  amended
    13  by section 2 of part DD of chapter 57 of the laws of 2018, is amended to
    14  read as follows:
    15    22.  "Administer",  for the purpose of section sixty-eight hundred one
    16  of this article, means:
    17    a. the direct application of an immunizing agent to adults, whether by
    18  injection, ingestion, inhalation or  any  other  means,  pursuant  to  a
    19  patient  specific  order  or  non-patient specific regimen prescribed or
    20  ordered by a physician or certified nurse practitioner, who has a  prac-
    21  tice site in the county or adjoining county in which the immunization is
    22  administered,  for  immunizations  to  prevent  influenza, pneumococcal,
    23  acute herpes zoster, meningococcal, tetanus,  diphtheria,  COVID-19,  or
    24  pertussis  disease  and  medications required for emergency treatment of
    25  anaphylaxis. If the commissioner of health determines that there  is  an
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD16067-04-0

        A. 10508--A                         2
 
     1  outbreak of disease, or that there is the imminent threat of an outbreak
     2  of  disease,  then  the  commissioner  of health may issue a non-patient
     3  specific regimen applicable statewide.
     4    b.  the  direct application of an immunizing agent to children between
     5  the ages of two and eighteen years of age, whether by injection,  inges-
     6  tion,  inhalation  or  any  other  means, pursuant to a patient specific
     7  order or non-patient specific regimen prescribed or ordered by a  physi-
     8  cian  or  certified  nurse  practitioner, who has a practice site in the
     9  county or adjoining county in which the  immunization  is  administered,
    10  for immunization to prevent influenza and medications required for emer-
    11  gency  treatment of anaphylaxis resulting from such immunization. If the
    12  commissioner of health determines that there is an outbreak of  influen-
    13  za,  or  that  there is the imminent threat of an outbreak of influenza,
    14  then the commissioner of health may issue a non-patient specific regimen
    15  applicable statewide.
    16    § 3. Subdivision 7 of section 6909 of the education law, as amended by
    17  chapter 46 of the laws of 2015, is amended to read as follows:
    18    7. A certified nurse practitioner may prescribe and  order  a  patient
    19  specific order or non-patient specific regimen to a licensed pharmacist,
    20  pursuant  to regulations promulgated by the commissioner, and consistent
    21  with the public health law, for administering immunizations  to  prevent
    22  influenza,  pneumococcal,  acute  herpes zoster, meningococcal, tetanus,
    23  diphtheria, COVID-19, or pertussis disease and medications required  for
    24  emergency  treatment  of  anaphylaxis. Nothing in this subdivision shall
    25  authorize unlicensed persons to administer  immunizations,  vaccines  or
    26  other drugs.
    27    §  4.  This  act shall take effect no sooner than ninety days from the
    28  date of approval of a COVID-19 immunization by the  United  States  Food
    29  and  Drug  Administration's Center for Biologics Evaluation and Research
    30  and shall expire and be deemed repealed July 1, 2022;  provided  further
    31  that this act shall not take effect until the commissioner of health and
    32  the commissioner of education jointly certify that the administration of
    33  such  immunization pursuant to this act would be in the best interest of
    34  public health; provided that the commissioner of health and the  commis-
    35  sioner  of  education shall notify the legislative bill drafting commis-
    36  sion upon the occurrence of such certification in order that the commis-
    37  sion may maintain an accurate and timely  effective  data  base  of  the
    38  official  text  of  the  laws of the state of New York in furtherance of
    39  effectuating the provisions of section 44 of  the  legislative  law  and
    40  section 70-b of the public officers law; provided further, that:
    41    (a)  the  amendments to subdivision 7 of section 6527 of the education
    42  law made by section one of this act shall not affect the  expiration  of
    43  such subdivision and shall be deemed to expire therewith;
    44    (b)  the amendments to subdivision 22 of section 6802 of the education
    45  law made by section two of this act shall not affect the repeal of  such
    46  subdivision pursuant to section 8 of chapter 563 of the laws of 2008, as
    47  amended, and shall be deemed repealed therewith; and
    48    (c)  the  amendments to subdivision 7 of section 6909 of the education
    49  law, made by section three of this act shall not affect  the  expiration
    50  of such subdivision and shall be deemed to expire therewith.
Go to top